A detailed history of High Tower Advisors, LLC transactions in Dynavax Technologies Corp stock. As of the latest transaction made, High Tower Advisors, LLC holds 39,018 shares of DVAX stock, worth $484,603. This represents 0.0% of its overall portfolio holdings.

Number of Shares
39,018
Previous 85,484 54.36%
Holding current value
$484,603
Previous $959,000 54.74%
% of portfolio
0.0%
Previous 0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$10.05 - $11.61 $466,983 - $539,470
-46,466 Reduced 54.36%
39,018 $434,000
Q2 2024

Aug 13, 2024

SELL
$10.73 - $12.58 $75,270 - $88,248
-7,015 Reduced 7.58%
85,484 $959,000
Q1 2024

May 06, 2024

BUY
$11.7 - $14.98 $39,054 - $50,003
3,338 Added 3.74%
92,499 $1.15 Million
Q4 2023

Feb 12, 2024

BUY
$13.09 - $14.98 $17,318 - $19,818
1,323 Added 1.51%
89,161 $1.25 Million
Q3 2023

Nov 08, 2023

SELL
$12.64 - $14.99 $104,709 - $124,177
-8,284 Reduced 8.62%
87,838 $1.3 Million
Q2 2023

Aug 14, 2023

BUY
$9.85 - $13.17 $141,180 - $188,765
14,333 Added 17.52%
96,122 $1.24 Million
Q1 2023

May 11, 2023

BUY
$9.44 - $11.88 $172,195 - $216,703
18,241 Added 28.7%
81,789 $802,000
Q4 2022

Feb 08, 2023

BUY
$10.27 - $13.29 $1,386 - $1,794
135 Added 0.21%
63,548 $676,000
Q3 2022

Nov 09, 2022

BUY
$9.93 - $17.44 $629,691 - $1.11 Million
63,413 New
63,413 $654,000
Q2 2022

Aug 10, 2022

SELL
$7.45 - $12.83 $107,868 - $185,765
-14,479 Closed
0 $0
Q1 2022

May 12, 2022

BUY
$9.75 - $14.44 $141,170 - $209,076
14,479 New
14,479 $159,000

Others Institutions Holding DVAX

About DYNAVAX TECHNOLOGIES CORP


  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.57B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track High Tower Advisors, LLC Portfolio

Follow High Tower Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.